UT Horizon Fund logo

UT Horizon Fund

North America, Texas, United States, Austin

Description

The UT Horizon Fund is a distinctive strategic venture capital fund established by the University of Texas System. Launched with a significant commitment, its primary mission is to foster innovation and commercialization by investing in early- and middle-stage companies that demonstrate a direct connection to one of the UT System's institutions. This unique mandate positions the fund not merely as a financial investor but as a strategic partner aiming to leverage the vast intellectual capital and research capabilities residing within the UT System's universities and health institutions.

The fund's investment strategy is deeply rooted in supporting the entrepreneurial ecosystem emerging from the University of Texas. It specifically targets companies founded by UT faculty, students, or alumni, as well as ventures that are commercializing intellectual property licensed from UT System institutions. While sector-agnostic in principle, this focus naturally leads to investments in areas where UT excels, such as life sciences, deep technology, software, and advanced materials. The fund seeks companies with high growth potential, aiming to provide not just capital but also strategic guidance and access to the extensive UT network.

Financially, the UT Horizon Fund was established with a substantial $300 million allocation from the UT System's Permanent University Fund, underscoring the System's long-term commitment to this initiative. This capital enables the fund to make meaningful investments that can significantly impact a company's trajectory. Typical initial investments from the UT Horizon Fund range from $1 million to $5 million, with the flexibility and capacity to participate in subsequent funding rounds as portfolio companies scale. This approach ensures sustained support for promising ventures, contributing to both their success and the broader economic development within Texas and beyond.

Investor Profile

UT Horizon Fund has backed more than 32 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 13% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $1M – $5M.

Stage Focus

  • Series A (25%)
  • Seed (22%)
  • Convertible Note (19%)
  • Series B (13%)
  • Series C (13%)
  • Series Unknown (9%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Software
  • Medical Device
  • Information Technology
  • Pharmaceutical
  • Manufacturing
  • Telecommunications
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UT Horizon Fund frequently co-invest with?

Sidecar Angels
North America, Massachusetts, United States, Somerville
Co-Investments: 2
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Boston Harbor Angels
North America, Massachusetts, United States, Boston
Co-Investments: 2
Co-Investments: 2
Capital Factory
North America, Texas, United States, Austin
Co-Investments: 2
M12 - Microsoft's Venture Fund
North America, California, United States, San Francisco
Co-Investments: 2
ATP Fund
North America, Texas, United States, Austin
Co-Investments: 2
Green Park & Golf Ventures
North America, Texas, United States, Dallas
Co-Investments: 3
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
Leawood Venture Capital
North America, Kansas, United States, Leawood
Co-Investments: 2

Which angels does UT Horizon Fund often collaborate with?

LL
North America, Texas, United States, Houston
Shared Deals: 1
LT
North America, California, United States, San Jose
Shared Deals: 1

What are some of recent deals done by UT Horizon Fund?

Cerebri AI

Austin, Texas, United States

Cerebri AI provides customers with "Answers-as-a-Service" using our CVX real-time AI software platform.

Artificial Intelligence (AI)Enterprise SoftwareInformation TechnologyMachine LearningSaaSSoftware
Convertible NoteDec 4, 2019
Amount Raised: $7,000,000
Cerebri AI

Austin, Texas, United States

Cerebri AI provides customers with "Answers-as-a-Service" using our CVX real-time AI software platform.

Artificial Intelligence (AI)Enterprise SoftwareInformation TechnologyMachine LearningSaaSSoftware
Series AJun 28, 2018
Amount Raised: $5,000,000
GenXComm

Austin, Texas, United States

GenXComm enables true full duplex for next generation communications infrastructure.

Information ServicesInformation TechnologySoftwareTelecommunicationsWireless
Series ADec 12, 2017
Amount Raised: $7,000,000
Cardiovate

San Antonio, Texas, United States

Cardiovate is a medical technology company that targets transformational health care opportunities in tissue regeneration and repair.

Health CareMedicalMedical Device
SeedNov 21, 2017
Amount Raised: $1,000,000
Astrocyte Pharmaceuticals

Cambridge, Massachusetts, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
SeedJul 17, 2017
Amount Raised: $2,400,000
GenXComm

Austin, Texas, United States

GenXComm enables true full duplex for next generation communications infrastructure.

Information ServicesInformation TechnologySoftwareTelecommunicationsWireless
SeedJun 20, 2017
Amount Raised: $1,500,000
Lung Therapeutics

Austin, Texas, United States

Lung Therapeutics provides innovative treatments for underserved, life-threatening lung conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series BJun 6, 2017
Amount Raised: $14,300,000
Astrocyte Pharmaceuticals

Cambridge, Massachusetts, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
SeedMar 24, 2017
Amount Raised: $1,355,279
Alafair Biosciences

Austin, Texas, United States

Alafair Biosciences specializes in commercializing biomaterials and biomedical devices that enhance internal wound healing.

BiotechnologyHealth CareMedical Device
Series AAug 9, 2016
Amount Raised: $2,000,000
Decisio Health

Houston, Texas, United States

Decisio Health is a elping care providers.

Health CareInformation TechnologyMedical
Series BMay 18, 2016
Amount Raised: $4,500,000